Multiple Sclerosis
Conference Coverage
Cautionary findings on acquired immunodeficiency from anti-CD20 MS therapy
Clinicians are advised to monitor patients with MS much closer for signs of hypogammaglobulinemia and lymphopenia starting with year 2 on therapy...
Conference Coverage
Five-year siponimod data support early MS treatment
During an open-label extension, patients who initially received placebo before switching to siponimod were more likely to have confirmed...
Conference Coverage
Report details first case of PML with ocrelizumab alone
The first case of PML directly associated with ocrelizumab occurred in a 78-year-old male with primary progressive MS.
News
Database will collect data on COVID-19 in patients with MS
A registry is gathering information on patients throughout the United States with a view to understanding outcomes and improving treatment.
News
FDA removes pregnancy category C warning from certain MS medications
Labeling updates include more information on using certain MS drugs during pregnancy and breastfeeding.